Severe Osteoporosis in Men

  1. Nicky Kelepouris, MD;
  2. Kristine D. Harper, MD;
  3. Francis Gannon, MD;
  4. Frederick S. Kaplan, MD; and
  5. John G. Haddad, MD
  1. From the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. Acknowledgments: The authors miss Drs. Maurice F. Attie and Michael Fallon, who died during completion of these studies, and thank Ms. Cordelia Shute and our general clinical research center staff for their help in conducting these studies and J. Simms for secretarial assistance. Grant Support: Supported in part by grants MO1-RR00040, RO1 AM28292, AM32760, and T32-AR07481 from the National Institutes of Health and by the Hartford Foundation Fellowship on Aging. Requests for Reprints: John G. Haddad, MD, Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, 611 Clinical Research Building, 415 Curie Boulevard, Philadelphia, PA 19104-6149. Current Author Addresses: Dr. Kelepouris: Mercy-Fitzgerald Medical Office Building, Suite 206, 1501 Lansdowne Avenue, Darby, PA 19023.
     
    Next Section

    Abstract

    Objective: To evaluate men with severe osteoporosis for pathogenetic factors and to review the reported features of primary osteoporosis in men.

    Design: Case series and clinical review.

    Patients: 47 men consecutively referred to a metabolic bone center because of atraumatic (or minimally traumatic) fractures (91%) or radiographic osteopenia (9%).

    Measurements: Clinical assessment, radiographs, chemical analyses of serum and urine, hormone assays, skeletal densitometry, and histomorphometry of iliac crest biopsy specimens.

    Results: 27 of the 47 men (57%) had vertebral fractures, and 16 (34%) had appendicular fractures. Causal factors identified in 30 men (64%) included glucocorticosteroid treatment (8 men); hypogonadism (7 men); excessive alcohol consumption (7 men); and anticonvulsant use, osteomalacia, severe hyperthyroidism, or bone marrow neoplasia (8 men). Seventeen men (36%) had no medical conditions or known risk factors associated with bone disease. Spinal mineral density was well below the mean value for healthy young men in 94% of the patients with primary osteoporosis tested. Examination of biopsy specimens from 13 of 17 men with primary osteoporosis showed reduced trabecular bone volumes, normal bone formation rates, and slightly increased resorption surfaces. Fasting hypercalciuria was seen in some men (41%). In the primary osteoporosis group, eight men were followed serially (range of follow-up, 6 months to 9 years) while they were receiving a nonpharmacologic regimen (diet and activity); the mean axial bone mineral density of these men increased slightly.

    Conclusions: A thorough evaluation for identifiable causes of severe osteoporosis in men is warranted because definable pathogenetic factors are seen in many cases. A few men with severe osteoporosis have primary or idiopathic osteoporosis. Primary osteoporosis in men is probably caused by many factors because heterogeneous clinical, laboratory, and histologic features were seen in our series and in those of others. Further studies of primary osteoporosis are needed to define the course of the disease, to identify pathogenetic mechanisms, and to develop therapeutic interventions.

    Osteoporosis is less common in men than in women, presumably because men have a greater bone mass than women at all ages [1, 2], a shorter life expectancy than women, and no distinct equivalent to menopause. The incidence of hip fractures in men after age 50 years is half the incidence in women, and most fractures occur after age 70 years [3]. Vertebral fractures, the most common osteoporotic fractures in women, are unusual in nonelderly men (younger than age 70 years) [4, 5]; because of this, these men might be expected to have underlying disorders that prevented attainment of bone mass at skeletal maturity or that caused rapid bone loss. On the other hand, considerable evidence suggests that men and women have similar bone densities (with volume considered) [6-9], and analyses of female and male co-twin pairs indicates similar bone density, if not bone mass, between the sexes [10]. Aging-related bone densities have been studied in vertebral bodies (trabecular and cortical), and these data indicate that the greater loss in women may be due to a greater loss of cortical bone [1, 6, 11]. Men's spines show greater subperiosteal cortical bone formation and less endocortical resorption than occurs in women; this results in a larger cross-sectional vertebral diameter in men [9] and may contribute to the relatively greater breaking strength of the male vertebral body [12, 13].

    Osteoporosis in men has been associated with diseases and drugs that threaten bone mass, such as hypogonadism, hyperthyroidism, excessive alcohol intake, smoking, and exposure to high-dose glucocorticoids [14-23]. In some instances, however, the cause of the osteoporosis is not apparent. Primary or idiopathic osteoporosis in adults does occur in men [16, 20, 22, 24-31]. Susceptibility to vertebral fractures has been recognized, and the hypercalciuria noted in previous studies has varied [16, 20, 24-31]. Both high and low skeletal turnover rates have been reported [16].

    Our metabolic bone disease unit is a regional referral service for patients with osteoporosis and other metabolic bone diseases. We consecutively evaluated men with osteopenia over 7 years, and our clinical, biochemical, densitometric, and histomorphometric observations indicate that secondary osteoporosis is common in men with severe osteoporosis. We also reviewed 14 clinical reports of primary osteoporosis in men (377 cases) and compared the reported features with our findings from 17 patients for whom a cause of osteoporosis could not be determined.

    Previous SectionNext Section

    Methods

    Patients

    Forty-seven white men were referred to the Metabolic Bone Disease clinic at the Hospital of the University of Pennsylvania between 1980 and 1987. All referrals were prompted by fractures with no or minimal trauma or with severe osteopenia. All patients gave informed consent and were evaluated at our general clinical research center. At the center, the patients were provided a diet that matched their usual calcium intake, as determined from a diet history obtained by our nutritionist. Relevant roentgenograms were provided by referring physicians or were obtained during the evaluation. Previous medical records were reviewed to determine the patients' earlier medical disorders and treatments. Each patient completed a questionnaire designed to identify risk factors associated with skeletal compromise. Family members were interviewed to corroborate medical and social histories. At the time of evaluation, the patients with primary osteoporosis had no history of familial osteoporosis, delayed puberty [19], insulin-dependent diabetes mellitus, severe arthritis, malabsorption, gastrointestinal surgery, or malignant disease. None of these patients deviated more than 15% from their ideal body weight, and none had a history of serious concurrent medical illnesses or use of any drugs recognized to unfavorably affect bone metabolism [13, 16, 22]. Investigations were done to exclude secondary osteoporosis.

    Biochemical Analyses

    After an overnight fast, the following blood tests were done in our hospital's clinical laboratories: hematology profile; serum protein electrophoresis; and measurement of serum calcium, inorganic phosphorus, albumin, creatinine, alkaline phosphatase, electrolyte, hepatic enzyme, immunoreactive parathyroid hormone (carboxy-terminal assay), thyroxine, triiodothyronine resin uptake, thyroid-stimulating hormone, and testosterone levels. Tests to measure 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels were done by Nichols Laboratories (San Juan Capistrano, California). Twenty-four-hour urine specimens were analyzed for calcium, phosphorus, creatinine, and free cortisol levels. Fasting, second-void urine specimens were analyzed for calcium and creatinine levels.

    Bone Mineral Densitometry

    Bone mineral density of the lumbar spine was measured by quantitative computed tomography or dual-photon absorptiometry, or both. The latter technique was not available before 1984. Dual-photon absorptiometry of L1 to L4 (Lunar Radiation Corporation, Madison, Wisconsin) was done with a gadolinium source in a DP-3 scanner [32]. Quantitative computed tomography of T12 to L4 was done with a GE9800 computed tomographic scanner (General Electric, Milwaukee, Wisconsin) using previously described methods [33]. In follow-up studies, bone mineral density of the lateral spine was analyzed with a Lunar dual-energy x-ray absorptiometer, and reference values were obtained for age-matched normal men [34]. We did not do paired analyses with the dual-photon and dual-energy x-ray instruments. Bone density was expressed as the T score (number of standard deviations from the average value for healthy young men). We used the method of Eastell and colleagues [35] to assess nonovert vertebral fractures.

    Bone Histomorphometry

    In 35 men (74%), a full-thickness, transiliac bone biopsy specimen was obtained after tetracycline dual labeling. The cylindric biopsy specimens were processed undecalcified according to a standard protocol [36]. The following variables were quantitated using 200 microscopic fields: trabecular bone volume (percentage of total), trabecular wall thickness (microns), total osteoid surface (mm2/mm3), osteoclasts (cells per mm2 of medullary space), eroded surface (percentage of total), and bone formation rate (µ m3/mu m2 per year). The findings were compared with normal, age-matched male values reported in the literature.

    Statistical Analysis

    We calculated summary values and variances for patient characteristics and intergroup comparisons. Because our study did not include a paired, normal group, we interpreted our biochemical data in comparison with the laboratories' normal ranges. Because histomorphometric data for normal men were available, we used reference values that reflected a normal population and that matched the ages of our study group. Several patients in the idiopathic osteoporosis group were available for follow-up visits and repeated densitometric measurements. These data included unequal spacing and different lengths of follow-up and were therefore subjected to a random-effects regression analysis [37]. This approach permits an estimate of the effect of time within each patient, which is then averaged over patients; this gives more precision to the analysis of the trend over time.

    Previous SectionNext Section

    Results

    Clinical Presentation

    Clinical characteristics are shown in Table 1. Forty-three patients (91%) were referred because of fractures. Twenty-seven men (57%) had vertebral fractures, and 16 (34%) had appendicular fractures. Four patients (9%) were referred because of the incidental recognition of radiographic osteopenia, and all patients were found to have primary osteoporosis.

    View this table:
    Table 1. Clinical and Densitometric Characteristics of Osteoporotic Men*

    We grouped our patients according to the presence or absence of factors associated with osteoporosis (Table 1). Disorders that are known to be associated with bone loss were found in 30 men (64%). Group 1 (secondary osteoporosis) was composed of men with disorders that commonly cause osteoporosis and was subdivided according to the patients' underlying disorders. Group 1A consisted of seven men who had previously taken glucocorticoids (> 25 g of prednisone [or equivalent] total lifetime dose) but were not taking it at the time of the metabolic bone disease work-up and of one man with surgically documented Cushing disease. Group 1B consisted of seven men with excessive alcohol intake (> 100 g/d for many years), and group 1C consisted of seven men with primary or secondary hypogonadism.

    We chose not to tabulate a miscellaneous group of men with the following diagnoses: osteomalacia related to renal phosphate wasting, aluminum antacid use, or anticonvulsant therapy (four patients); hyperthyroidism (two patients); osteoporosis related to anticonvulsant use (one patient); and multiple myeloma (one patient).

    Group 2 (primary or idiopathic osteoporosis) consisted of 17 men (36%) who had no recognized condition or collection of risk factors associated with osteoporosis (Table 1).

    Bone Densitometry

    Densitometry showed strikingly low values in all groups studied, as would be expected from our referral pattern. For all groups, lower density was found with quantitative computed tomography (trabecular bone only) compared with the integral (cortical and trabecular bone) vertebral density measured by the dual-photon absorptiometry technique. Of 43 men measured, 94% had bone density values greater than 2 standard deviations below the mean value for healthy 30-year-old men. Thirty-six of 43 men (79%) were found to have bone density values greater than 2.5 standard deviations below the normal mean for young men.

    Biochemical Analyses

    Serum calcium, albumin, and creatinine levels and hemograms were usually in the normal range. Low serum phosphorus values were observed in the patients with renal phosphate-wasting. Total serum alkaline phosphatase levels were normal except in men with recent fracture, osteomalacia, and anticonvulsant use. Elevated hepatic aminotransferase levels were seen in three men in group 1B and one man in group 2; this latter patient was known to have hepatitis without cirrhosis. Serum vitamin D metabolite and C-terminal parathyroid hormone levels were within the normal range except for levels in two patients with osteomalacia. Mean serum testosterone levels were strikingly lower in the patients in group 1C (6.1 mmol/L) than levels in group 2 patients (22.3 mmol/L) and values in the normal reference range (12.5 to 31 mmol/L).

    The 24-hour urinary excretion of free cortisol and serum thyroid function test results were normal in all groups. All men had normal creatinine clearances. The mean (±SD) 24-hour excretion of urinary calcium was in the high end of the normal range (3.7 ± 1.8 mg/kg body weight) for patients in group 2. In six patients (35%) in group 2, the 24-hour urinary excretion of calcium was 4 mg/kg or greater while they were receiving a moderate amount of daily calcium (12 to 25 mmol/d). The mean fasting calciuria level was normal in all groups, but the mean fasting calcium/creatinine ratio was at the high end of the normal range (0.136 ± 0.09) in the patients in group 2. Studies were not repeated during dietary calcium restriction.

    Bone Biopsy Specimens

    In the men with primary osteoporosis, histologic variables were compared with published data for healthy men aged 20 to 44 years and 46 to 75 years [27, 28, 38, 39]. As expected, cancellous bone volume was considerably lower in the younger men with primary osteoporosis and in all of the older men (Table 2). Osteoid surface and thickness of the trabecular wall did not differ from published normal values, indicating that osteoblastic activity had not markedly decreased. Bone formation rates varied widely and did not differ from the control values found in the literature. Percentages of eroded surface were modestly increased in both age groups within the primary osteoporotic group. The osteoclast numbers were slightly increased. Thus, clear increases in bone resorption variables were not seen in our patients.

    View this table:
    Table 2. Findings from Skeletal Histomorphometry*

    Follow-up Studies

    Of the 17 men with idiopathic osteoporosis, 5 elected to receive pharmacologic treatment (calcitonin, thiazides, sodium fluoride, or bisphosphonate), 2 were lost to follow-up, and 2 died of unrelated conditions. The remaining 8 men did not choose any management other than low-impact, moderate physical activity; avoidance of heavy lifting; and elemental calcium supplementation of their diets to a total intake of 1 g/d. These men reported no further fractures. Repeated bone mineral density testing was done over a period of 6 months to 9 years after diagnosis. Trend analysis, by random-effects regression [37], showed a slight (0.02 standard deviations per year) average increase in spinal bone mineral density during the conservative management of these men.

    Follow-up spinal bone mineral density measurements were done in three of the five men receiving pharmacologic treatment. In two men intermittently receiving oral sodium fluoride, 40 mg/d, bone mineral density improved by 46% (as shown by quantitative computed tomography after 30 months of drug treatment) and 24% (as shown by dual energy x-ray absorptiometry after 22 months of treatment), respectively. In another patient intermittently receiving disodium etidronate, 10 mg/kg per day, spinal bone mineral density increased by 14% (as shown by dual-energy x-ray absorptiometry after 20 months of therapy). None of these three men developed any further skeletal morbid conditions. Two other patients began receiving thiazide or calcitonin but did not return for reevaluation.

    Previous SectionNext Section

    Discussion

    We found that severe osteoporosis in nonelderly men was usually associated with conditions known to be major causes of bone loss. Approximately two thirds of our referred patients had diseases, medication use, or lifestyles that have been linked to substantial bone loss [16]. In published series (Table 3), secondary causes of osteoporosis are found in 26% to 72% of patients (some of the series included likely secondary causes among the patients with primary osteoporosis). The true incidence of idiopathic osteoporosis in men is difficult to determine because population characteristics and referral patterns differ so widely. However, Khosla and colleagues [27] have recently reported that osteoporosis in young persons occurs at an incidence rate of 4.1/105 patient-years, with a female to male ratio of 1.2/1.0.

    View this table:
    Table 3. Review of Published Data from Men with Primary Osteoporosis*
    View this table:
    Table 3—continued

    Secondary Osteoporosis

    Among men with secondary osteoporosis, several conditions are repeatedly found in previous studies: glucocorticoid excess; hypogonadism; liver disease and excessive ethanol consumption; severe, miscellaneous medical conditions; gastrointestinal diseases and surgery; protracted immobilization; and heavy tobacco use [13-31]. In our series, we detected excessive glucocorticoids (17% of patients), hypogonadism (15%), and excessive alcohol consumption (15%) as major causal factors. Our findings resemble those of Seeman and colleagues [22], Jackson and colleagues [17], Francis and colleagues [26], and Resch and colleagues [31].

    It is well recognized that excessive glucocorticoid exposure unfavorably uncouples bone remodeling and leads rapidly to skeletal morbid conditions. Patients exposed to steroids can develop hypercalciuria, secondary hypogonadism, and mildly elevated serum parathyroid hormone levels [13, 16, 21, 22, 38, 40, 41]. As in women, hypogonadism in men is a serious threat to skeletal integrity [14-17, 19]; the evolution of this disorder may be insidious because its nonskeletal features may not be clinically apparent in as many as 50% of cases [30]. Hypogonadism might play a role in aging-related bone loss in men [13, 42, 43], but the differentially regional bone loss in women that develops after menopause appears more convincing [1, 4]. The recent report of a 28-year-old man with osteoporosis and an estrogen receptor mutation suggests that androgen indirectly affects the skeleton [44]. Longitudinal studies of bone density in aging men have shown substantial appendicular and axial bone loss [45]. Seven of our patients reported long-term heavy ethanol consumption, and six of the seven had vertebral fractures as well as severe osteoporosis (Table 1). Alcohol excess has clearly been associated with markedly reduced rates of bone formation [17, 46] and decreased vertebral cancellous density [46]. Appendicular and rib fractures are also seen [13, 30, 47], and osteoporosis can develop in young alcoholic men before cirrhosis is seen [48].

    Primary Osteoporosis

    Fractures and Bone Mineral Density

    Our patients with primary osteoporosis (Table 1, group 2) had severe axial osteoporosis, and 47% had spine fractures. This fracture incidence is similar to incidences reported for primary osteoporosis in men (Table 3) in studies in which selection was not determined by the presence of vertebral fractures [25, 27, 29, 39] associated with minimal to no trauma. Although we did not measure appendicular bone mineral density, five of six previous reports found low opacity in the hand, forearm, or hip, and 5 of our 17 patients with primary osteoporosis sustained appendicular fractures during minimal trauma. Together, our data and published reports suggest that primary osteoporosis in men is associated with both cancellous and cortical bone loss.

    Biochemical Tests

    Hypercalciuria is a frequent finding in the reported cases of primary osteoporosis in men (7 of 11 published series), apparently occurring more frequently than idiopathic hypercalciuria in normal men. In studies in which calciuria was measured while patients received full and restricted amounts of dietary calcium [25, 29, 39], calciuria was sharply reduced during dietary restriction. These findings suggest intestinal hyperabsorption of calcium. We observed fasting calciuria values at the high end of normal range and values higher than normal in 7 (41%) of our 17 patients with primary osteoporosis; this finding is similar to one by Resch and colleagues [31]. Hypercalciuria can also indicate bone resorptive or renal mechanisms, but most published information does not clearly indicate strongly increased bone resorption or renal leak of calcium as the reasons for hypercalciuria in primary osteoporosis. Furthermore, studies of calcium balance have shown a spectrum of results with no consistent imbalances [26, 29]. Francis and colleagues [26] described decreased intestinal absorption of calcium in 10 men with primary osteoporosis and reduced plasma 1,25-dihydroxyvitamin D concentrations within the normal range. Zerwekh and coworkers [25] found normal calcium absorption in 12 of 16 patients and increased absorption in 4 men with increased plasma 1,25-dihydroxyvitamin D concentrations. The published experience (Table 3) indicates that hypercalciuria frequently occurs in men with primary osteoporosis, but the mechanism of this condition has not been consistently defined.

    Urine hydroxyproline excretion was measured in a few studies [24-2629, 31], but inconsistent results (normal or high excretion) were seen in men with primary osteoporosis. Because more specific biochemical markers of bone resorption and formation have recently been developed, their applications in this condition will be of interest.

    Blood parathyroid hormone levels are uniformly reported to be normal or at the low end of the normal range, and, except for some subgroups, vitamin D metabolite levels are usually in the normal range. Decreased 25-hydroxyvitamin D levels were seen in persons with poor nutrition [20]. Our patients without a diagnosis of osteomalacia had normal parathyroid hormone and vitamin D metabolite levels.

    Skeletal Histologic Findings

    The skeletal histologic findings reported in primary osteoporosis have been used to help sort out the nature of the bone loss mechanisms involved. Of 11 studies of biopsy specimens (excluding our paper), 9 have shown some decrease in osteoblastic activity [17, 20, 24-2839, 49, 50], especially in cancellous bone. In young men with primary osteoporosis, decreases in osteoid and osteoblast surfaces were frequently seen, along with decreased bone formation rates and decreased numbers of trabeculae without thinning. The amount of trabecular bone formed by osteoblasts during a remodeling cycle (mean wall thickness) was not reduced in our series (Table 2), but a reduction has been seen in young (< 50 years) persons in two of five series [27, 40]. This latter finding may suggest a premature onset of the sluggish osteoblast activity seen in the elderly [51]. However, a wide spectrum of wall thickness values was seen in these studies, indicating a heterogeneous histologic picture compared with available normal data. In these studies, bone resorption measurements, which are generally less secure, varied and were not usually increased in absolute terms. In most studies of young patients, the bone loss in primary osteoporosis therefore appears to be due to an absolute decrease in bone-forming activity and a relative and modest increase in resorptive activity. In our patients (Table 2), failure to clearly detect such changes was probably due to our center's lack of normal reference data, the small number of patients studied, and generally recognized interlaboratory variations.

    Heterogeneous Features of Primary Osteoporosis in Men

    A review of the series of primary osteoporosis in men leads us to conclude that most of the reported findings are not consistently seen. For example, calciuria, calcium balance alterations, and increased hydroxyprolinuria are not uniformly present. Bone histologic findings indicate some decreased osteoblastic activity in most cases, but increased bone resorption measures have also been reported. However, evidence (when examined) for both cortical and trabecular bone loss is convincing. A confounding factor in previous clinical reports has been the sparse characterization of patients and the inclusion of now-recognized patients with secondary osteoporosis along with the patients with primary osteoporosis [20, 30, 52, 53].

    Patient Management

    Little information is available on the course or treatment of primary osteoporosis in men [54-56]. Most of the related information has been derived from studies in women or from relatively short-term analyses of bone mineral density changes or biochemical changes in men [54-56]. All the antifracture efficacy studies evaluating therapy for osteoporosis have been done in osteoporotic women [56]. The only controlled trial to evaluate calcium supplementation in healthy, aging men did not show a beneficial effect on spinal or appendicular bone density [45]. We observed stable to slightly increased bone mineral density during conservative management of a subgroup of our patients with primary osteoporosis. However, we cannot fairly extrapolate our findings to all patients with primary osteoporosis because our follow-up involved only a few, severely affected men during a time when our densitometric technology changed. Substantial bone loss in men, as with women [2], may be followed by a slower rate of loss. It is also conceivable that some men have primary osteoporosis as a result of attaining a low peak bone mineral density earlier in life [56].

    Previous SectionNext Section

    Conclusions

    Osteoporosis in men is a relatively neglected disorder, but most thorough evaluations of severe cases should show secondary causes. Primary osteoporosis in men is not rare, appears to be heterogeneous in many of its features, and involves the axial and appendicular skeleton. Because we currently have sparse data on pathogenetic mechanisms and almost no information on the course or treatment of primary osteoporosis in men, more analyses and effort, possibly in multicenter studies and trials, are welcome.

    Dr. Harper: Bone and Metabolic Diseases, Duke University, 702 Trent Drive, Durham, NC 27705.

    Dr. Gannon: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 6 Founders, 34th and Spruce Streets, Philadelphia, PA 19104.

    Dr. Kaplan: Department of Orthopaedic Surgery, University of Pennsylvania, 2 Silverstein, 34th and Spruce Streets, Philadelphia, PA 19104.

    Dr. Haddad: Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, 611 Clinical Research Building, 415 Curie Boulevard, Philadelphia, PA 19104-6149.

    Previous Section
     

    References

    1. 1.↵
      Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ 3d. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981; 67:328-35.
    2. 2.↵
      Mazess RB. On aging bone loss. Clin Orthop. 1982; 165:239-52.
    3. 3.↵
      Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985; 7:178-208.
    4. 4.↵
      Riggs BL, Melton LJ 3d. Involutional osteoporosis. N Engl J Med. 1986; 1314:1676-86.
    5. 5.↵
      Melton LJ. Epidemiology of fractures. In: Riggs BL, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis, and Management. New York: Raven; 1988:133-54.
    6. 6.↵
      Genant HK, Ettinger B, Harris ST, Block JE, Steiger P. Quantitative computed tomography in assessment of osteoporosis. In Riggs BL, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis, and Management. New York: Raven; 1988:221-50.
    7. 7.↵
      Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, Bonjour JP. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab. 1992; 75:1060-5.
    8. 8.↵
      Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. 1983; 72:1396-409.
    9. 9.↵
      Mosekilde L, Mosekilde L. Sex differences in age-related changes in vertebral body size, density and biochemical competence in normal individuals. Bone. 1990; 11:67-73.
    10. 10.↵
      Kelly PJ, Twomey L, Sambrook PN, Eisman JA. Sex differences in peak adult bone mineral density. J Bone Miner Res. 1990; 5:1169-75.
    11. 11.↵
      Kalender WA, Felsenberg D, Louis O, Lopez P, Klotz E, Osteaux M, et al. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol. 1989; 9:75-80.
    12. 12.↵
      Biggermann M, Hilweg D, Brinckmann P. Prediction of the compressive strength of vertebral bodies of the lumbar spine by quantitative computed tomography. Skeletal Radiol. 1988; 17:264-9.
    13. 13.↵
      Seeman E. Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities. Am J Med. 1993; 95(5A):22S-8S.
    14. 14.↵
      Foresta C, Ruzza A, Mioni R, Guarneri G, Gribaldo R, Meneghel A, et al. Osteoporosis and decline of gonadal functions in the elderly male. Horm Res. 1984; 19:18-22.
    15. 15.↵
      Greenspan SL, Neer RM, Ridgway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1986; 104:777-82.
    16. 16.↵
      Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine (Baltimore). 1990; 69:137-52.
    17. 17.↵
      Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab. 1987; 65:53-8.
    18. 18.↵
      Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med. 1989; 86:282-8.
    19. 19.↵
      Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992; 326:600-4.
    20. 20.↵
      de Vernejoul MC, Bielakoff J, Herve M, Gueris J, Hott M, Modrowski D, et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop. 1983; 179:107-15.
    21. 21.↵
      Bressot C, Meunier PJ, Chapuy MC, Lejune E, Edouard C, Darby AJ. Histomorphometric profile, pathophysiology and reversibility of corticosteroid induced osteoporosis. Metabolic Bone Disease and Related Research. 1979; 1:303-11.
    22. 22.↵
      Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med. 1983; 75:977-82.
    23. 23.↵
      Stepan JJ, Lachman M, Zverima J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989; 69:523-27.
    24. 24.↵
      Bordier PJ, Miravet L, Hioco D. Young adult osteoporosis. Clin Endocrinol Metab. 1973; 2:277-92.
    25. 25.↵
      Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporosis Int. 1992; 2:128-34.
    26. 26.↵
      Francis RM, Peacock M, Marshall DH, Horsman A, Aaron JE. Spinal osteoporosis in men. Bone Miner. 1989; 5:347-57.
    27. 27.↵
      Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ 3d. Epidemiology and clinical features of osteoporosis in young individuals. Bone. 1994; 15:551-5.
    28. 28.↵
      Nordin BE, Aaron J, Speed R, Francis RM, Makins N. Bone formation and resorption as the determinants of trabecular bone volume in normal and osteoporotic men. Scott Med J. 1984; 29:171-5.
    29. 29.↵
      Hioco D, Miravet L, Bordier PH. Physiology and treatment of osteoporosis in younger men. In: Blackwood H, ed. Bone and Tooth. New York: Pergamon Pr; 1964:365-97.
    30. 30.↵
      Baillie SP, Davison CE, Johnson FJ, Francis RM. Pathogenesis of vertebral crush fractures in men. Age Aging. 1992; 21:139-41.
    31. 31.↵
      Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R. Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest. 1992; 22:542-5.
    32. 32.↵
      Wahner HW, Dunn WL, Mazess RB, Towsley M, Lindsay R, Markhard L, Dempster D. Dual photon Gd-153 absorptiometry of bone. Radiology. 1985; 156:203-6.
    33. 33.↵
      Kaplan FS, Dalinka M, Karp JS, Fallon MD, Katz M, Boden S, et al. Quantitative computed tomography reflects vertebral fracture morbidity in osteopenic patients. Orthopedics. 1989; 12:949-55.
    34. 34.↵
      Mazess R. Normal values for spine and femur bone density. Lunar R2/90. Madison, WI: Lunar Corp; 1990.
    35. 35.↵
      Kaplan FS, Scherl JD, Wisneski R, Cheatle M, Haddad JG. The cluster phenomenon in patients who have multiple vertebral compression fractures. Clin Orthop. 1993; 297:161-7.
    36. 36.↵
      Kaplan FS, Soffer SR, Fallon MD, Haddad JG, Dalinka M, Raffensperger EC. Osteomalacia as a very late manifestation of primary hyperparathyroidism. Clin Orthop. 1988; 228:26-32.
    37. 37.↵
      Fleiss JL. The Design and Analysis of Clinical Experiments. New York: J Wiley; 1986.
    38. 38.↵
      Aaron JE, Francis RM, Peacock M, Makins NB. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop. 1989; 243:294-305.
    39. 39.↵
      Perry HM 3d, Fallon MD, Bergfeld M, Teitelbaum SL, Avioli LV. Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. Arch Intern Med. 1982; 142:1295-8.
    40. 40.↵
      MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med. 1986; 104:648-51.
    41. 41.↵
      Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 1989; 4:137-41.
    42. 42.↵
      Meier DE, Orwoll ES, Jones JM. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by verterbral computed tomography and radial photon absorptiometry. Ann Intern Med. 1984; 101:605-12.
    43. 43.↵
      Meier DE, Orwoll ES, Keenan EJ, Fagerstrom RM. Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. J Am Geriatr Soc. 1987; 35:189-97.
    44. 44.↵
      Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994; 331:1056-61.
    45. 45.↵
      Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med. 1990; 112:29-34.
    46. 46.↵
      Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, et al. Bone disease in alcohol abuse. Ann Intern Med. 1985; 104:42-8.
    47. 47.↵
      Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med. 1989; 86:282-8.
    48. 48.↵
      Spencer H, Rubio N, Rubio E, Indreika M, Seitam A. Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am J Med. 1986; 80:393-7.
    49. 49.↵
      Hills E, Dunstan CR, Wong SY, Evans RA. Bone histology in young adult osteoporosis. J Clin Pathol. 1989; 42:391-7.
    50. 50.↵
      Marie PJ, deVernejoul MC, Connes D, Hott M. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest. 1991; 88:1167-72.
    51. 51.↵
      Lips P, Courpron P, Meunier PJ. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res. 1978; 26:13-7.
    52. 52.↵
      Jackson WPU. Osteoporosis of unknown cause in younger people (Idiopathic Osteoporosis). J Bone Joint Surg. 1958; 40B:420-41.
    53. 53.↵
      Saville PD. The syndrome of spinal osteoporosis. Clin Endocrinol Metab. 1973; 2:177-85.
    54. 54.↵
      Orwoll ES, Bliziotes M. Heterogeneity in osteoporosis. Men versus women. Rheum Dis Clin North Am. 1994; 20:671-89.
    55. 55.↵
      Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev. 1995; 16:87-116.
    56. 56.↵
      Seeman E. The dilemma of osteoporosis in men. Am J Med. 1995; 98(2A):76-88.
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med September 15, 1995 vol. 123 no. 6 452-460
    1. AbstractFREE
    2. » Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Navigate This Article

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues